068330.KQ ilShinbiobase Co. Ltd
- Market cap
- KRW 42.1B
- P/E
- -
- P/B
- 0.63x
- ROE
- 7.8%
- Dividend yield
- 0.69%
- Fundamental score
- 2.0/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 068330.KQ undervalued?
Graham numberThe Graham number of ilShinbiobase Co. Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ilShinbiobase Co. Ltd fundamental analysis
9 of 22 checks passedROE 0/2
Low return on equity (7.8%), below 10%.
ROA 1/1
Return on assets (7.1%) is above the industry median (2.7%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (25.8%) is above the industry median (-4.2%).
Revenue Growth 0/2
Revenue shrank 10.7% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Debt is not reported.
Interest Coverage 1/1
No interest expense reported.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (0.6x) is below the industry median (0.8x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
Dividend yield (0.7%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 2/2
Dividends paid without a cut of more than 10% for 11 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 6.1%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
ilShinbiobase Co. Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About ilShinbiobase Co. Ltd
ilShinbiobase Co. Ltd. manufactures and sells industrial refrigeration equipment in Korea. It offers laboratory, pilot, and plant scale, as well as auto loading/unloading systems; deep and quick freezers; and blood bank and pharmaceutical refrigerators. The company also provides ice makers and shakers. It also exports its products to approximately 100 countries. The company was formerly known as iLShinLab Co., Ltd. and changed its name to ilShinbiobase Co. Ltd. in 2009. The …
Full company profileilShinbiobase Co. Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
ilShinbiobase Co. Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 13.4B | 12.8B | 15.4B | 19.6B | 21.0B | 24.4B | 20.4B | 16.4B | 10.8B | 14.5B | 13.4B |
| Gross Profit | 6.32B | 6.09B | 6.94B | 10.9B | 10.4B | 13.1B | 10.5B | 9.43B | 6.28B | 7.72B | 7.40B |
| Operating Income | 3.01B | 2.34B | 3.04B | 5.21B | 5.02B | 7.78B | 5.16B | 6.21B | 2.26B | 4.56B | 3.96B |
| EBITDA | - | - | - | - | - | - | 5.17B | 8.22B | 2.70B | 5.00B | 4.38B |
| Net Income | 2.69B | 2.10B | 3.16B | 4.65B | 4.48B | 6.24B | 3.82B | 6.23B | 3.81B | 4.79B | 5.25B |
| EPS | - | - | - | - | - | - | 89 | 150 | 91 | 115 | 126 |
| Balance Sheet | |||||||||||
| Total Assets | 37.7B | 38.5B | 39.5B | 45.6B | 49.5B | 56.8B | 58.5B | 60.6B | 63.9B | 68.6B | 73.8B |
| Total Liabilities | 4.68B | 3.27B | 3.81B | 5.47B | 5.17B | 6.36B | 4.63B | 3.55B | 3.49B | 3.79B | 6.72B |
| Shareholders' Equity | 33.0B | 35.2B | 35.7B | 40.2B | 44.4B | 50.5B | 53.8B | 57.1B | 60.4B | 64.8B | 67.1B |
| Cash & Short-term Investments | 10.1B | 11.3B | 12.8B | 17.6B | 20.2B | 25.6B | 5.71B | 3.15B | 1.73B | 1.98B | 2.72B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 3.01B | 2.11B | 4.88B | 5.55B | 4.50B | 6.74B | 2.65B | 5.92B | 4.12B | 5.27B | 7.77B |
| Capital Expenditure | 272M | 408M | 386M | 245M | 893M | 139M | 523M | 262M | 53.5M | 20.6M | 77.1M |
| Free Cash Flow | - | - | - | - | - | - | 2.12B | 5.66B | 4.07B | 5.25B | 7.76B |
| Ratios | |||||||||||
| ROE | 8.2% | 6.0% | 8.9% | 11.6% | 10.1% | 12.4% | 7.1% | 10.9% | 6.3% | 7.4% | 7.8% |
| ROA | 7.1% | 5.5% | 8.0% | 10.2% | 9.0% | 11.0% | 6.5% | 10.3% | 6.0% | 7.0% | 7.1% |
| Net Profit Margin | 20.2% | 16.4% | 20.5% | 23.7% | 21.3% | 25.6% | 18.7% | 37.9% | 35.2% | 33.0% | 39.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ilShinbiobase Co. Ltd dividends
- Dividend yield
- 0.69%
- Forward dividend
- -
- Payout ratio
- 6.1%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 292M | 7.00 | 6.1% |
| 2024 | KRW 292M | 7.00 | 7.7% |
| 2023 | KRW 300M | 7.20 | 4.8% |
| 2022 | KRW 300M | 7.00 | 7.9% |
| 2021 | KRW 300M | - | 4.8% |
| 2020 | KRW 300M | - | 6.7% |
| 2019 | KRW 214M | - | 4.6% |
| 2018 | KRW 214M | - | 6.8% |
| 2017 | KRW 214M | - | 10.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 5:1 on Feb 11, 2014.
Who owns ilShinbiobase Co. Ltd
- Insiders 30.66%
- Institutions 0.57%
- Public & others 68.76%
- Shares outstanding 41.7M
- Free float 29.3M
ilShinbiobase Co. Ltd company profile
- Company name
- ilShinbiobase Co. Ltd
- Ticker
- 068330.KQ
- ISIN
- KR7068330000
- Exchange
- KOSDAQ
- Sector
- -
- Industry
- Machinery
- Fiscal year end
- December
- Address
- 84, Samyuksa-ro 548beon-gil, Dongducheon-Si, South Korea
- Phone
- 82 70 4354 3951
- Website
- 1sbb.com
About ilShinbiobase Co. Ltd
ilShinbiobase Co. Ltd. manufactures and sells industrial refrigeration equipment in Korea. It offers laboratory, pilot, and plant scale, as well as auto loading/unloading systems; deep and quick freezers; and blood bank and pharmaceutical refrigerators. The company also provides ice makers and shakers. It also exports its products to approximately 100 countries. The company was formerly known as iLShinLab Co., Ltd. and changed its name to ilShinbiobase Co. Ltd. in 2009. The company was founded in 1988 and is headquartered in Dongducheon, South Korea.
ilShinbiobase Co. Ltd management
3- Mr. Seong-Dae HongChief Exec. Officer and Representative Director · born 1959
- Bang Taek LimDirector of Domestic Sales
- Jae-Yong KimChief of R&D Center and Director · born 1968